Cetirizine Hydrochloride Tablets 5 mg
Cetirizine HCl 5 mg tablets recalled over possible Ranitidine cross contamination; lots GY825029–GY825032.
Check your bottle for NDC 16571-401-10 and lot numbers GY825029, GY825030, GY825031, or GY825032. If affected, stop using and contact Rising Pharma Holdings Inc. at 1-844-874-7464 or pv@risingpharma.com for return and refund instructions.
Why it was recalled
Unique Pharmaceutical Laboratories is recalling Cetirizine Hydrochloride Tablets USP 5 mg, 100-count HDPE containers, due to potential cross contamination with Ranitidine. The affected lots are GY825029, GY825030, GY825031, and GY825032, with NDC 16571-401-10 and expiration 10/2028.
Is mine affected?
Check the lot code and best-by (or expiration) date printed on your package. Yours is affected if it matches one below.
Cetirizine Hydrochloride Tablets USP 5 mg, Pack 100’s HDPE containerBest-by: 10/2028NDC: 16571-401-10Distribution: Rising Pharma Holdings Inc.Manufacturer: Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.)
| Lot code |
|---|
| GY825029 |
| GY825030 |
| GY825031 |
| GY825032 |
Where it was sold
Distributed nationwide.
Official source
Editorial summary by Recall Canary · last updated 2026-07-18 · primary source: U.S. Food and Drug Administration